Greenwich LifeSciences The Overlooked Need (NASDAQ:GLSI)
· seekingalpha.com
Greenwich LifeSciences is a single-asset biotech focused on GLSI-100, an immunotherapy for HER2-positive breast cancer. Learn why GLSI stock is a buy.
Greenwich LifeSciences ( GLSI ) is a single-asset small-cap biotechnology company. The current market capitalization of Greenwich supports my belief that the ma...